Le Lézard
Classified in: Health
Subjects: CHI, CSR

ABC Fine Wine & Spirits partners with National Pediatric Cancer Foundation to raise funds for childhood cancer research


The Florida family-owned wine and spirits retailer leads its 11th campaign benefiting NPCF

ORLANDO, Fla., Aug. 4, 2022 /PRNewswire/ -- ABC Fine Wine & Spirits (ABC), Florida's largest family-owned and operated wine and spirits retailer, is once again partnering with National Pediatric Cancer Foundation (NPCF) and Constellation Brands to raise vital funds for childhood cancer research. ABC guests can donate at store registers or contribute by purchasing select wines from July 31 to Oct. 1, 2022. The campaign is part of National Childhood Cancer Awareness Month in September.

"ABC and our team members throughout the state are proud to support charities that champion children and families," said CEO Charles Bailes III. "NPCF is a life-changing organization with an incredible reputation that works to ensure that every child can live a long, happy life, and the research they fund allows for extraordinary work."

NPCF is a top-rated nonprofit organization dedicated to research and clinical trials to find less toxic, more effective treatments for childhood cancer. The foundation was created when two mothers met through their daughters' cancer diagnoses and decided to pursue measurable change in the field of pediatric oncology.

"We are grateful for the ongoing support from ABC Fine Wine & Spirits. The Bailes family, with their exceptional Florida workforce and customer base, has embraced raising funds for the National Pediatric Cancer Foundation's research mission," NPCF CEO David Frazer said. "As a result, over $1.3 million has been provided for critical science ? specifically right here in Florida at the University of Florida, Johns Hopkins All Children's Hospital, Moffitt Cancer Center and more."

Guests can donate at checkout or by purchasing products from participating Constellation Wine brands like Robert Mondavi Private Selection, Ruffino, SIMI, Kim Crawford, Meiomi, Cooper & Thief, Unshackled and Saldo. A portion of each sale of those bottles will go to NPCF.

To learn more about this partnership and donate, please visit abcfws.com/npcf. Keep up with ABC on these platforms: Instagram, Facebook, TikTok, Twitter and YouTube.

About ABC Fine Wine & Spirits

Orlando-based ABC Fine Wine & Spirits currently has 125 stores throughout Florida with 8 more underway. The company has been family-owned and operated since 1936.

Media Contacts
Ms. Peyton Whittington
ABC Fine Wine & Spirits
Communications Specialist
[email protected]
407.738.0310

Mr. Christopher Geib
National Pediatric Cancer Foundation
Chief Development Officer
[email protected]

 

SOURCE ABC Fine Wine & Spirits


These press releases may also interest you

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...



News published on and distributed by: